Global Spinal Cord Stimulation Devices Revenue Is Nearly 2.15 Billion USD In 2017
Warning: date() expects parameter 2 to be long, string given in /www/wwwroot/www.globalinforesearch.com/static/themes/default/info_detail.php on line 32
In the last several years, global market of spinal cord stimulation devices was experienced an upward trend rapidly, with an average growth rate of 5.72%. In 2017, global revenue of spinal cord stimulation devices is nearly 2.15 billion USD; the actual Sales are about 116 K Unit.
The classification of spinal cord stimulation devices includes rechargeable type and non-rechargeable type. The proportion of rechargeable type in 2017 is about 66%, and the proportion is in increasing trend from 2013 to 2017.
Spinal cord stimulation devices are widely used in failed?back?surgery?syndrome, complex?regional?pain?syndrome, chronic?pain and other field. The most proportion of spinal cord stimulation devices is for failed?back?surgery?syndrome, and the proportion in 2017 is 43.95%.
North America is the largest consumption place, with a consumption market share nearly 56% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 24%.
Market competition is intense. Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro,
Nuvectra are the leaders of the industry. And top 3 account for around 79% of the total market share. These existing companies are making investments in several research activities to launch new devices.